GPX4 and liver cancer: Currently, several conventional clinical drugs, such as the liver cancer‐targeting drug sorafenib and the anti‐inflammatory drug for inflammatory bowel disease, sulfasalazine, promote tumor cell ferroptosis by targeting key signaling pathways like Glutathione Peroxidase 4 (GPX4).